Skip to main content

Peer Review reports

From: Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)

Original Submission
10 Feb 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
18 May 2015 Editorially accepted
8 Jul 2015 Article published 10.1186/s12885-015-1444-1

You can find further information about peer review here.

Back to article page
\